HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$0.38
Day range
$0.32 - $0.36
Year range
$0.30 - $4.17
Market cap
17.05M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 214.00K | -37.24% |
Operating expense | 12.78M | -70.92% |
Net income | -13.65M | 72.96% |
Net profit margin | -6.38K | 56.92% |
Earnings per share | -0.32 | 79.78% |
EBITDA | -13.66M | 68.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.39M | -55.11% |
Total assets | 48.89M | -51.33% |
Total liabilities | 134.52M | -4.63% |
Total equity | -85.63M | — |
Shares outstanding | 42.75M | — |
Price to book | -0.19 | — |
Return on assets | -60.09% | — |
Return on capital | -141.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.65M | 72.96% |
Cash from operations | -16.34M | 56.53% |
Cash from investing | — | — |
Cash from financing | 454.00K | — |
Net change in cash | -15.88M | 57.74% |
Free cash flow | -10.14M | 45.41% |
About
Founded
2017
Headquarters
Website
Employees
74
